Literature DB >> 34062295

Ferroptosis suppressive genes correlate with immunosuppression in glioblastoma.

Shaokang Deng1, Yaofeng Zhenga1, Yunzhao Mo1, Xiangdong Xu1, Yan Li1, Yuxuan Zhang1, Jie Liu1, Jianqiu Chen1, Yixin Tian1, Yiquan Ke2.   

Abstract

Glioblastoma (GBM) is the most lethal primary tumor in the central nervous system. Ferroptosis is an iron-dependent cell death. This study aims to identify prognostic ferroptosis-related genes and their role in tumor immunity. We identified by differential and survival analysis that a ferroptosis suppressor was predominant within ferroptosis-related genes with The Cancer Genome Atlas (TCGA) GBM RNA-Seq data. By integrating TCGA and gene expression omnibus (GEO) GBM cohorts, 12 dysregulated ferroptosis suppressors were detected. Among the suppressors, CD44, HSPB1, and SLC40A1 were relevant to overall survival. We then observed using systematic bioinformatic methods a ferroptosis suppressor correlated with immunosuppression that could be attributed to T cell exhaustion and cytotoxic T lymphocyte (CTL) evasion. Finally, we observed that a potential ferroptosis-inducing drug, acetaminophen, interacted with CD44, HSPB1, and SLC40A1. Our study is expected to be of great significance in developing new immunotherapy strategies for GBM.
Copyright © 2021. Published by Elsevier Inc.

Entities:  

Keywords:  CTL evasion; GBM; T cell exhaustion; acetaminophen; ferroptosis; immunosuppression

Year:  2021        PMID: 34062295     DOI: 10.1016/j.wneu.2021.05.098

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  11 in total

1.  Prognosis and Immune Landscapes in Glioblastoma Based on Gene-Signature Related to Reactive-Oxygen-Species.

Authors:  Prashant Kaushal; Junle Zhu; Zhiping Wan; Huairui Chen; Jingliang Ye; Chun Luo
Journal:  Neuromolecular Med       Date:  2022-07-02       Impact factor: 3.843

Review 2.  Iron Transporters and Ferroptosis in Malignant Brain Tumors.

Authors:  Jingyu Zhao; Yaqi Wang; Lei Tao; Ligong Chen
Journal:  Front Oncol       Date:  2022-04-21       Impact factor: 5.738

3.  LncRNA PELATON, a Ferroptosis Suppressor and Prognositic Signature for GBM.

Authors:  Haijuan Fu; Zhaoyu Zhang; Danyang Li; Qingqing Lv; Simin Chen; Zuping Zhang; Minghua Wu
Journal:  Front Oncol       Date:  2022-04-28       Impact factor: 5.738

4.  m6A Regulatory Gene-Mediated Methylation Modification in Glioma Survival Prediction.

Authors:  Guiyun Zhang; Ping Zheng; Yisong Lv; Zhonghua Shi; Fei Shi
Journal:  Front Genet       Date:  2022-04-26       Impact factor: 4.772

Review 5.  Genetic Profiles of Ferroptosis in Malignant Brain Tumors and Off-Target Effects of Ferroptosis Induction.

Authors:  Marc Dahlmanns; Eduard Yakubov; Jana Katharina Dahlmanns
Journal:  Front Oncol       Date:  2021-12-01       Impact factor: 6.244

Review 6.  Ferroptosis Involvement in Glioblastoma Treatment.

Authors:  Andrei-Otto Mitre; Alexandru Ioan Florian; Andrei Buruiana; Armand Boer; Ioana Moldovan; Olga Soritau; Stefan Ioan Florian; Sergiu Susman
Journal:  Medicina (Kaunas)       Date:  2022-02-20       Impact factor: 2.430

7.  Prognostic value and immune relevancy of a combined autophagy-, apoptosis- and necrosis-related gene signature in glioblastoma.

Authors:  Ying Bi; Zeng-Hong Wu; Fei Cao
Journal:  BMC Cancer       Date:  2022-03-03       Impact factor: 4.430

8.  Expression profiles and functions of ferroptosis-related genes in intimal hyperplasia induced by carotid artery ligation in mice.

Authors:  Lina Zhang; Wei Li; Bo Shi; Xiaoqing Zhang; Kaizheng Gong
Journal:  Front Genet       Date:  2022-08-30       Impact factor: 4.772

9.  Characterization of peripheral white blood cells transcriptome to unravel the regulatory signatures of bovine subclinical mastitis resistance.

Authors:  Jinyan Yang; Yongjie Tang; Xueqin Liu; Jinning Zhang; Muhammad Zahoor Khan; Siyuan Mi; Chuduan Wang; Ying Yu
Journal:  Front Genet       Date:  2022-09-20       Impact factor: 4.772

10.  Hepcidin is upregulated and is a potential therapeutic target associated with immunity in glioma.

Authors:  Tianyu Dong; Bo Zhang; Runjiao Zhang; Chang Wang; Xiaopeng Liu; Fei Wang; Nana Hao; Ke Tan; Yan-Zhong Chang
Journal:  Front Oncol       Date:  2022-09-27       Impact factor: 5.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.